Bifidumbacterin, lyophilizate 5 doses 10 pcs

Diarrhea, Colitis, Bloating, Dysbacteriosis, Intestinal infections, Constipation

In diseases of the gastrointestinal tract:

• for the treatment of long-term intestinal dysfunction of unspecified etiology;
• in acute intestinal infections (in the complex treatment of acute dysentery, salmonellosis, escherichiosis, viral diarrhea, etc.п.), prolonged intestinal dysfunctions of staphylococcal aetiology as well as for treatment of relapsed patients after acute intestinal infections with continued intestinal dysfunction;
• . In complex treatment of children (including infants, prematurely born) with pneumonia, sepsis and other purulent-infectious diseases, for prevention or relief of intestinal dysfunction and prevention of ulcerous-necrotic enterocolitis development;

.

• for treatment and prevention of dysbacteriosis in children with a history of premorbid conditions, born prematurely or with signs of prematurity who received antibiotics in the early neonatal period; Children whose mothers have had severe toxicosis, extragenital diseases, prolonged waterless period or other pathologies; children of mothers who have had lactastasis, cracked nipples and resume breastfeeding after recovery from mastitis; Weakened children with anaemia, hypotrophy, rickets, diathesis, and other manifestations of allergy; whooping cough-especially if they have any bowel dysfunction;
• In early transition to complementary feeding or donor milk;
• For infants for the treatment of acute and chronic inflammatory diseases of the large and small intestine (colitis, enterocolitis) in older children and adults, occurring against a background of microflora disorders with a deficit or absence of Bifidobacterium in intestinal dysfunction as a result of dysbacteriosis of the intestine, resulting from prolonged antibacterial, hormonal, radiation and other therapy, in stressful situations and under extreme conditions, as well as for the prevention of dysbacteriosis in these individuals.

In obstetric and gynecological practice:

• for the prevention of mastitis for local treatment of the mammary glands of nursing mothers of the “risk” group (in women with retracted flat nipple, with a decrease in its erection, the presence of fissures) in a burdened epidemiological situation in maternity hospitals;
• in violation of purity of vaginal secretion to degree III – IV in pregnant women of “risk” group;
• in bacterial colpitis caused by Staphylococcus and E. coli (in monoflora or in associations), as well as in senile colpitis of hormonal nature.

.

Indications

For diseases of the gastrointestinal tract:

for the treatment of long-term intestinal dysfunctions of unknown etiology;
for acute intestinal infections (in the complex treatment of acute dysentery, salmonellosis, escherichiosis, viral diarrhea, etc.), long-term intestinal dysfunction of staphylococcal etiology, as well as for the treatment of convalescents after acute intestinal infections with ongoing intestinal dysfunction;
in the complex treatment of children (including newborns, premature babies), patients with pneumonia, sepsis and other purulent-infectious diseases, for the prevention or relief of intestinal dysfunction in them and to prevent the development of necrotizing ulcerative enterocolitis;
for the treatment and prevention of dysbiosis in children with a burdened premorbid condition, born prematurely or with signs of prematurity, receiving antibiotics in the early neonatal period; children whose mothers suffered from severe toxicosis, extragenital diseases, had a long anhydrous period or other pathology; children of mothers who had lactostasis, cracked nipples and resumed breastfeeding after recovery from mastitis; weakened children with anemia, malnutrition, rickets, diathesis and other manifestations of allergies; with whooping cough, especially if they have any intestinal dysfunction;
with early transfer of infants to artificial feeding or feeding with donor milk;
for the treatment of acute and chronic inflammatory diseases of the large and small intestines (colitis, enterocolitis) in older children and adults, occurring against the background of microflora disorders with deficiency or absence of bifid flora;
for intestinal dysfunctions as a result of intestinal dysbiosis, which arose as a result of long-term antibacterial, hormonal, radiation and other therapy, in stressful situations and exposure to extreme conditions, as well as for the purpose of preventing dysbiosis for these individuals.

In obstetrics and gynecology practice:

for the purpose of preventing mastitis for local treatment of the mammary glands of nursing mothers at risk (women with an inverted flat nipple, with a decrease in its erection, the presence of cracks) in aggravated epidemiological situations in maternity hospitals;
in case of violation of the purity of vaginal secretion up to III – IV degree in pregnant women of the “risk” group;
for bacterial colpitis caused by staphylococcus and Escherichia coli (in monoflora or in associations), as well as for senile colpitis of a hormonal nature.

Special instructions

The drug does not affect the performance of activities requiring special attention and quick reactions (driving vehicles, machinery, etc.).

Active ingredient

Bifidobacterium bifidum

Composition

One dose of the drug contains at least 107 live bifidobacteria.

Excipient:

Lactulose – 2%, components of the drying medium: sucrose, gelatin, skim milk (skimmed milk).

Pregnancy

Bifidobacteria are representatives of the normal human microflora, therefore preparations made on their basis can be used during pregnancy and lactation.

Interaction

Clinically significant interactions of the drug with other drugs have not been established. Bifidumbacterin can be used simultaneously with antibacterial, antiviral and immunomodulatory therapy. The effect is enhanced by vitamins (especially group B), and reduced by antibiotics. Corrective therapy with bifidumbacterin can be prescribed after a course of treatment with specific bacteriophages designed to eliminate opportunistic bacteria.

Storage conditions

The drug is stored in accordance with SP 3.3.2.1248-03, at a temperature not exceeding 10° C, out of the reach of children.

Transportation conditions.

Transportation is carried out in accordance with SP 3.3.2.1248-03, at a temperature not exceeding 10° C.

Not suitable for use:

upon expiration of the expiration date, or stored in non-compliance with regulated conditions;
the integrity of the packaging is compromised (cracked bottles);
no markings on the bottle;
with altered physical properties (change in color, shrinkage of biomass), or in the presence of foreign inclusions.

Shelf life

2 years.

Manufacturer

Ecopolis, Russia